Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenylketonuria: an update.

Stephen Cederbaum1

  • 1Departments of Psychiatry, Pediatrics and Human Genetics, and the Mental Retardation Research Center, David Geffen School of Medicine at UCLA, Los Angeles, California 90024-1759, USA. scederbaum@mednet.ucla.edu

Current Opinion in Pediatrics
|November 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma arginine levels in arginase deficiency in the "real world".

Molecular genetics and metabolism reports·2024
Same author

Characterization of spastic paraplegia in a family with a novel <i>PSEN1</i> mutation.

Brain communications·2023
Same author

Arginine to ornithine ratio as a diagnostic marker in patients with positive newborn screening for hyperargininemia.

Molecular genetics and metabolism reports·2021
Same author

Myopathy, lactic acidosis and sideroblastic anemia 1 (MLASA1): A 25-year follow-up.

Molecular genetics and metabolism reports·2019
Same author

Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria.

Molecular genetics and metabolism·2018
Same author

Biochemical markers and neuropsychological functioning in distal urea cycle disorders.

Journal of inherited metabolic disease·2018

Phenylketonuria (PKU) is a key metabolic disorder. This review covers PKU

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Phenylketonuria (PKU) is a significant inborn error of metabolism.
  • PKU research has advanced understanding, diagnosis, and treatment of metabolic disorders.

Purpose of the Study:

  • To review the current knowledge of PKU.
  • To explore novel therapeutic strategies for PKU.

Main Methods:

  • Literature review of recent publications on PKU.
  • Analysis of studies on cofactor supplementation and genetic/epigenetic modifications.

Main Results:

  • Current understanding of PKU diagnosis, treatment, molecular biology, and physiology is presented.
  • Emerging research in cofactor supplementation and gene expression modification is highlighted.

Related Experiment Videos

Conclusions:

  • Continued exploration of hyperphenylalaninemias, including PKU, is promising.
  • Novel therapeutic avenues offer hope for improved PKU management.